For more than 20 years, SSS has been successful within the area of clinical contract research (Full Service Contract Research) for the development of medicines and medical products. For further process professionalization and the development of the three subsidiaries in Germany, Poland and Romania, Dr. Michael Sigmund, until now the sole CEO of the company, has decided to bring reinforcements on board to create a future-orientated executive management.
From July 2017, Dr. Lars Behrend (45) will fill the role of COO, covering the key areas of financial management, controlling and business development. Lars Behrend holds a diploma in biology and a PhD in cancer research. He has 15 years work experience in management and consulting within the medical sector, biotechnology and cleantech areas.
“Having Dr. Lars Behrend on the team is a real stroke of luck. Here is a person who not only has extensive experience as a management executive and knows all about the clinical and biotechnology sectors. He also has a real entrepreneurial personality with hands-on experience in developing professional organisational structures and knowing the importance of cooperative customer relationships.” comments Dr. Michael Sigmund the personnel decision. “I have gained a sparring partner who exactly knows the critical phase when medicines move from theoretical research to the clinic. In future, I can concentrate more on the strategic development of our company.”